Molecular genetics of pediatric soft tissue tumors: Clinical application

Journal of Molecular Diagnostics

Volumn 5, Issue 3, 2003, Pages 143-154

  Chang, Chung Che ^a   Shidham, Vinod B ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; CHILD; CHILDHOOD CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE IDENTIFICATION; GENE THERAPY; HISTOPATHOLOGY; HUMAN; MEDICAL INFORMATION; METASTASIS; MINIMAL RESIDUAL DISEASE; MOLECULAR GENETICS; PATIENT MONITORING; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SOFT TISSUE TUMOR; TUMOR CLASSIFICATION;

EID: 0042065269     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60466-7     Document Type: Review

References (128)

1. Raney RB: Soft-tissue sarcoma in childhood and adolescence. Curr Oncol Rep 2002, 4:291-298
2. Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS: Intergroup rhabdomyosarcoma study-IV: results for patients with non-metastatic disease. J Clin Oncol 2001, 19:3091-3102
3. Burdach S, Jurgens H: High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT). Crit Rev Oncol Hematol 2002, 41:169-189
4. Pfeifer JD, Hill DA, O'Sullivan MJ, Dehner LP: Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics? Histopathology 2000, 37:485-500
5. Kilpatrick SE, Garvin AJ: Recent advances in the diagnosis of pediatric soft-tissue tumors. Med Pediatr Oncol 1999, 32:373-376
6. Ladanyi M, Bridge JA: Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol 2000, 31:532-538
7. Fletcher CD, Fletcher JA, Cin PD, Ladanyi M, Woodruff JM: Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics? Histopathology 2001, 39:100-103
8. Touriol C, Greenland C, Lamant L, Pulford K, Bernard F, Rousset T, Mason DY, Delsol G: Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like). Blood 2000, 95:3204-3207
9. Lamant L, Dastugue N, Pulford K, Delsol G, Mariame B: A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood 1999, 93:3088-3095
10. Lawrence B, Perez-Atayde A, Hibbard MK, Rubin BP, Dal Cin P, Pinkus JL, Pinkus GS, Xiao S, Yi ES, Fletcher CD, Fletcher JA: TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 2000, 157:377-384
11. Bridge JA, Kanamori M, Ma Z, Pickering D, Hill DA, Lydiatt W, Lui MY, Colleoni GW, Antonescu CR, Ladanyi M, Morris SW: Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol 2001, 159:411-415
12. Anderson J, Gordon T, McManus A, Mapp T, Gould S, Kelsey A, McDowell H, Pinkerton R, Shipley J, Pritchard-Jones K: Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Br J Cancer 2001, 85:831-835
13. Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr FG: PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol 2002, 20:2672-2679
14. de Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, Andrulis I, Sorensen PH, Barr FG, Ladanyi M: EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 1998, 16:1248-1255
15. de Alava E, Panizo A, Antonescu CR, Huvos AG, Pardo-Mindan FJ, Barr FG, Ladanyi M: Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma. Am J Pathol 2000, 156: 849-855
16. Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M: SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 1998, 338:153-160
17. Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JS, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O: Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 2002, 62:135-140
18. Ladanyi M, Chan WC, Triche TJ, Gerald WL: Expression profiling of human tumors: the end of surgical pathology? J Mol Diagn 2001, 3:92-97
19. West DC, Grier HE, Swallow MM, Demetri GD, Granowetter L, Sklar J: Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor. J Clin Oncol 1997, 15:583-588
20. Kelly KM, Womer RB, Barr FG: Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method. Cancer 1996, 78:1320-1327
21. Gattenloehner S, Dockhorn-Dworniczak B, Leuschner I, Vincent A, Muller-Hermelink HK, Marx A: A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas. J Mol Diagn 1999, 1:23-31
22. Willeke F, Sturm JW: Minimal residual disease in soft-tissue sarcomas. Semin Surg Oncol 2001, 20:294-303
23. Willeke F, Mechtersheimer G, Schwarzbach M, Weitz J, Zimmer D, Lehnert T, Herfarth C, von Knebel Doeberitz M, Ridder R: Detection of SYT-SSX1/2 fusion transcripts by reverse transcriptase- polymerase chain reaction (RT-PCR) is a valuable diagnostic tool in synovial sarcoma. Eur J Cancer 1998, 34:2087-2093
24. Athale UH, Shurtleff SA, Jenkins JJ, Poquette CA, Tan M, Downing JR, Pappo AS: Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor. J Pediatr Hematol Oncol 2001, 23:99-104
25. Bagg A: Chronic myeloid leukemia: a minimalistic view of post-therapeutic monitoring. J Mol Diagn 2002, 4:1-10
26. Lin F, van Rhee F, Goldman JM, Cross NC: Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood 1996, 87: 4473-4478
27. Dazzi F, Szydlo RM, Goldman JM: Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand. Exp Hematol 1999, 27:1477-1486
28. Tuveson DA, Fletcher JA: Signal transduction pathways in sarcoma as targets for therapeutic intervention. Curr Opin Oncol 2001, 13: 249-255
29. Tomescu O, Barr FG: Chromosomal translocations in sarcomas: prospects for therapy. Trends Mol Med 2001, 7:554-559
30. Scappaticci FA, Marina N: New molecular targets and biological therapies in sarcomas. Cancer Treat Rev 2001, 27:317-326
31. Maki RG: Soft tissue sarcoma as a model disease to examine cancer immunotherapy. Curr Opin Oncol 2001, 13:270-274
32. Bremer C, Tung CH, Weissleder R: In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 2001, 7:743-748
33. Lugo-Vicente H: Molecular biology and genetics affecting pediatric solid tumors. Bol Assoc Med P R 2000, 92:72-82
34. Hunt KK, Feig BW: Preclinical experimental therapeutic approaches in soft tissue sarcoma. Semin Surg Oncol 1999, 17:78-82
35. Allander SV, Illei PB, Chen Y, Antonescu CR, Bittner M, Ladanyi M, Meltzer PS: Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol 2002, 161:1587-1595
36. Worley BS, van den Broeke LT, Goletz TJ, Pendleton CD, Daschbach EM, Thomas EK, Marincola FM, Helman LJ, Berzofsky JA: Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations. Cancer Res 2001, 61:6868-6875
37. Antonescu CR, Tschernyavsky SJ, Woodruff JM, Jungbluth AA, Brennan MF, Ladanyi M: Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases. J Mol Diagn 2002, 4:44-52
38. Wang J, Hisaoka M, Shimajiri S, Morimitsu Y, Hashimoto H: Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues. Diagn Mol Pathol 1999, 8:113-119
39. Sheng WQ, Hisaoka M, Okamoto S, Tanaka A, Meis-Kindblom JM, Kindblom LG, Ishida T, Nojima T, Hashimoto H: Congenital-infantile filbrosarcoma: a clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues. Am J Clin Pathol 2001, 115:348-355
40. Antonescu CR, Kawai A, Leung DH, Lonardo F, Woodruff JM, Healey JH, Ladanyi M: Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma. Diagn Mol Pathol 2000, 9:1-8
41. Argani P, Fritsch M, Kadkol SS, Schuster A, Beckwith JB, Perlman EJ: Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Mod Pathol 2000, 13:29-36
42. Chen BF, Chen ML, Liang DC, Huang YW, Liu HC, Chen SH: Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue. Zhonghua Yi Xue Za Zhi (Taipei) 1999, 62:86-91
43. Okamoto S, Hisaoka M, Ishida T, Imamura T, Kanda H, Shimajiri S, Hashimoto H: Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 18 cases. Hum Pathol 2001, 32:1116-1124
44. Bagg A, Braziel RM, Arber DA, Bijwaard KE, Chu AY: Immunoglobulin heavy chain gene analysis in lymphomas: a multi-center study demonstrating the heterogeneity of performance of polymerase chain reaction assays. J Mol Diagn 2002, 4:81-89
45. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP: Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 1997, 22:130-131, 134-138
46. Bijwaard KE, Fetsch JF, Przygodzki R, Taubenberger JK, Lichy JH: Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction. J Mol Diagn 2002, 4:59-64
47. Hostein I, Menard A, Bui BN, Lussan C, Wafflart J, Delattre O, Peter M, Benhattar J, Guillou L, Coindre JM: Molecular detection of the synovial sarcoma translocation t(X;18) by real-time polymerase chain reaction in paraffin-embedded material. Diagn Mol Pathol 2002, 11:16-21
48. Merino ME, Navid F, Christensen BL, Toretsky JA, Helman LJ, Cheung NK, Mackall CL: Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reaction. J Clin Oncol 2001, 19:3649-3659
49. Peter M, Gilbert E, Delattre O: A multiplex real-time PCR assay for the detection of gene fusions observed in solid tumors. Lab Invest 2001, 81:905-912
50. Bridge JA, Liu J, Weibolt V, Baker KS, Perry D, Kruger R, Qualman S, Barr F, Sorensen P, Triche T, Suijkerbuijk R: Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer 2000, 27:337-344
51. Bridge JA, Liu J, Qualman SJ, Suijkerbuijk R, Wenger G, Zhang J, Wan X, Baker KS, Sorensen P, Barr FG: Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 2002, 33:310-321
52. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258:818-821
53. Ozaki T, Paulussen M, Poremba C, Brinkschmidt C, Rerin J, Ahrens S, Hoffmann C, Hillmann A, Wai D, Schaefer KL, Boecker W, Juergens H, Winkelmann W, Dockhorn-Dworniczak B: Genetic imbalances revealed by comparative genomic hybridization in Ewing tumors. Genes Chromosomes Cancer 2001, 32:164-171
54. Pandita A, Zielenska M, Thorner P, Bayani J, Godbout R, Greenberg M, Squire JA: Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma, Neoplasia 1999, 1:262-275
55. Skytting BT, Szymanska J, Aalto Y, Lushnikova T, Blomqvist C, Elomaa I, Larsson O, Knuutila S: Clinical importance of genomic imbalances in synovial sarcoma evaluated by comparative genomic hybridization. Cancer Genet Cytogenet 1999, 115:39-46
56. Tarkkanen M, Kiuru-Kuhlefelt S, Blomqvist C, Armengol G, Bohling T, Ekfors T, Virolainen M, Lindholm P, Monge O, Picci P, Knuutila S, Elomaa I: Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors. Cancer Genet Cytogenet 1999, 114:35-41
57. Szymanska J, Serra M, Skytting B, Larsson O, Virolainen M, Akerman M, Tarkkanen M, Huuhtanen R, Picci P, Bacchini P, Asko-Seljavaara S, Elomaa I, Knuutila S: Genetic imbalances in 67 synovial sarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer 1998, 23:213-219
58. Barnard M, Bayani J, Grant R, Zielenska M, Squire J, Thorner P: Comparative genomic hybridization analysis of clear cell sarcoma of the kidney. Med Pediatr Oncol 2000, 34:113-116
59. Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T: Multicolor spectral karyotyping of human chromosomes. Science 1996, 273:494-497
60. Roberts I, Gordon A, Wang R, Pritchard-Jones K, Shipley J, Coleman N: Molecular cytogenetic analysis consistently identifies translocations involving chromosomes 1, 2, and 15 in five embryonal rhabdomyosarcoma cell lines and a PAX-FOXO1A fusion gene negative alveolar rhabdomyosarcoma cell line. Cytogenet Cell Genet 2001, 95:134-142
61. Jalal SM, Law ME: Utility of multicolor fluorescent in situ hybridization in clinical cytogenetics. Genet Med 1999, 1:181-186
62. Triche TJ, Schofield D, Buckley J: DNA microarrays in pediatric cancer. Cancer J 2001, 7:2-15
63. Wai DH, Schaefer KL, Schramm A, Korsching E, Van Valen F, Ozaki T, Boecker W, Schweigerer L, Dockhorn-Dworniczak B, Poremba C: Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays. Int J Oncol 2002, 20:441-451
64. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX, Zhu S, Fero M, Sherlock G, Pollack JR, Brown PO, Botstein D, van de Rijn M: Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 2002, 359:1301-1307
65. Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM, Meltzer PS: Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 1998, 58:5009-5013
66. Qualman SJ, Morotti RA: Risk assignment in pediatric soft-tissue sarcomas: an evolving molecular classification. Curr Oncol Rep 2002, 4:123-130
67. Biegel JA, Nycum LM, Valentine V, Barr FG, Shapiro DN: Detection of the t(2;13)(q35;q14) and PAX3-FKHR fusion in alveolar rhabdomyosarcoma by fluorescence in situ hybridization. Genes Chromosomes Cancer 1995, 12:186-192
68. McManus AP, O'Reilly MA, Jones KP, Gusterson BA, Mitchell CD, Pinkerton CR, Shipley JM: Interphase fluorescence in situ hybridization detection of t(2;13)(q35;q14) in alveolar rhabdomyosarcoma: a diagnostic tool in minimally invasive biopsies. J Pathol 1996, 178: 410-414
69. Xia SJ, Pressey JG, Barr FG: Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther 2002, 1:97-104
70. Ladanyi M: The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol 1995, 4:162-173
71. Barr FG, Qualman SJ, Macris MH, Melnyk N, Lawlor ER, Strzelecki DM, Triche TJ, Bridge JA, Sorensen PH: Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res 2002, 62:4704-4710
72. Strachan T, Read AP: PAX genes. Curr Opin Genet Dev 1994, 4:427-438
73. Barr FG: Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene 2001, 20:5736-5746
74. Barber TD, Barber MC, Tomescu O, Barr FG, Ruben S, Friedman TB: Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma. Genomics 2002, 79:278-284
75. Feinberg AP: Genomic imprinting and gene activation in cancer. Nat Genet 1993, 4:110-113
76. Kojima T, Asami S, Chin M, Yoshida Y, Mugishima H, Suzuki T: Detection of chimeric genes in Ewing's sarcoma and its clinical applications. Biol Pharm Bull 2002, 25:991-994
77. Ladanyi M: EWS-FLI1 and Ewing's sarcoma: recent molecular data and new insights. Cancer Biol Ther 2002, 1:330-336
78. Udayakumar AM, Sundareshan TS, Goud TM, Devi MG, Biswas S, Appaji L, Arunakumari BS, Rajan KR, Prabhakaran PS: Cytogenetic characterization of Ewing tumors using fine needle aspiration samples: a 10-year experience and review of the literature. Cancer Genet Cytogenet 2001, 127:42-48
79. Sumerauer D, Vicha A, Kucerova H, Kodet R, Houskova J, Bedrnicek J, Eckschlager T: Detection of minimal bone marrow infiltration in patients with localized and metastatic Ewing sarcoma using RTPCR. Folia Biol 2001, 47:206-210
80. Zoubek A, Dockhorn-Dworniczak B, Delattre O, Christiansen H, Niggli F, Gatterer-Menz I, Smith TL, Jurgens H, Gadner H, Kovar H: Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 1996, 14:1245-1251
81. Lin PP, Brody RI, Hamelin AC, Bradner JE, Healey JH, Ladanyi M: Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Cancer Res 1999, 59:1428-1432
82. Bennicelli JL, Barr FG: Chromosomal translocations and sarcomas. Curr Opin Oncol 2002, 14:412-419
83. Chansky HA, Hu M, Hickstein DD, Yang L: Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res 2001, 61:3586-3590
84. Knoop LL, Baker SJ: EWS/FLI alters 5′-splice site selection. J Biol Chem 2001, 276:22317-22322
85. Arvand A, Welford SM, Teitell MA, Denny CT: The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1. Cancer Res 2001, 61:5311-5317
86. Girnita L, Girnita A, Wang M, Meis-Kindblom JM, Kindblom LG, Larsson O: A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells. Oncogene 2000, 19:4298-4301
87. de Alava E, Antonescu CR, Panizo A, Leung D, Meyers PA, Huvos AG, Pardo-Mindan FJ, Healey JH, Ladanyi M: Prognostic impact of P53 status in Ewing sarcoma. Cancer 2000, 89:783-792
88. Noguera R, Pellin A, Navarro S, Carda C, Llombart-Bosch A: Translocation (10;11;22)(p14;q24;q12) characterized by fluorescence in situ hybridization in a case of Ewing's tumor. Diagn Mol Pathol 2001, 10:2-8
89. Mastrangelo T, Modena P, Tornielli S, Bullrich F, Testi MA, Mezzelani A, Radice P, Azzarelli A, Pilotti S, Croce CM, Pierotti MA, Sozzi G: A novel zinc finger gene is fused to EWS in small round cell tumor. Oncogene 2000, 19:3799-3804
90. Gerald WL, Ladanyi M, de Alava E, Cuatrecasas M, Kushner BH, LaQuaglia MP, Rosai J: Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol 1998, 16:3028-3036
91. Ladanyi M, Gerald W: Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 1994, 54:2837-2840
92. Antonescu CR, Gerald WL, Magid MS, Ladanyi M: Molecular variants of the EWS-WT1 gene fusion in desmoplastic small round cell tumor. Diagn Mol Pathol 1998, 7:24-28
93. Benjamin LE, Fredericks WJ, Barr FG, Rauscher III FJ: Fusion of the EWS1 and WT1 genes as a result of the t(11;22)(p13;q12) translocation in desmoplastic small round cell tumors. Med Pediatr Oncol 1996, 27:434-439
94. Scharnhorst V, van der Eb AJ, Jochemsen AG: WT1 proteins: functions in growth and differentiation. Gene 2001, 273:141-161
95. Lee SB, Kolquist KA, Nichols K, Englert C, Maheswaran S, Ladanyi M, Gerald WL, Haber DA: The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour, Nat Genet 1997, 17:309-313
96. Brody RI, Ueda T, Hamelin A, Jhanwar SC, Bridge JA, Healey JH, Huvos AG, Gerald WL, Ladanyi M: Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am J Pathol 1997, 150:1049-1058
97. Dal Cin P, Sciot R, Panagopoulos I, Aman P, Samson I, Mandahl N, Mitelman F, Van den Berghe H, Fletcher CD: Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features. J Pathol 1997, 182:437-441
98. Barr FG: Translocations, cancer, and the puzzle of specificity. Nat Genet 1998, 19:121-124
99. Rabbitts TH: Perspective: chromosomal translocations can affect genes controlling gene expression and differentiation: why are these functions targeted? J Pathol 1999, 187:39-42
100. Sreekantaiah C, Ladanyi M, Rodriguez E, Chaganti RS: Chromosomal aberrations in soft tissue tumors: relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 1994, 144: 1121-1134
101. Yang P, Hirose T, Hasegawa T, Hizawa K, Sano T: Dual-colour fluorescence in situ hybridization analysis of synovial sarcoma. J Pathol 1998, 184:7-13
102. Brodin B, Haslam K, Yang K, Bartolazzi A, Xie Y, Starborg M, Lundeberg J, Larsson O: Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: sYT/SSX4, SYT/SSX4v, and SYT/SSX2v: possible regulatory role of the fusion gene product in wild-type SYT expression. Gene 2001, 268:173-182
103. Skytting B, Nilsson G, Brodin B, Xie Y, Lundeberg J, Uhlen M, Larsson O: A novel fusion gene, SYT-SSX4, in synovial sarcoma. J Natl Cancer Inst 1999, 91:974-975
104. Tornkvist M, Brodin B, Bartolazzi A, Larsson O: A novel type of SYT/SSX fusion: methodological and biological implications, Mod Pathol 2002, 15:679-685
105. Xie Y, Skytting B, Nilsson G, Gasbarri A, Haslam K, Bartolazzi A, Brodin B, Mandahl N, Larsson O: SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation. Cancer Res 2002, 62:3861-3867
106. Nagai M, Tanaka S, Tsuda M, Endo S, Kato H, Sonobe H, Minami A, Hiraga H, Nishihara H, Sawa H, Nagashima K: Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 α. Proc Natl Acad Sci USA 2001, 98:3843-3848
107. Sandberg AA, Bridge JA: Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: synovial sarcoma. Cancer Genet Cytogenet 2002, 133:1-23
108. Yoshida H, Nagao K, Ito H, Yamamoto K, Ushigome S: Chromosomal translocations in human soft tissue sarcomas by interphase fluorescence in situ hybridization. Pathol Int 1997, 47:222-229
109. Thomson B, Hawkins D, Felgenhauer J, Radich J: RT-PCR evaluation of peripheral blood, bone marrow, and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma. Bone Marrow Transplant 1999, 24:527-533
110. Langezaal SM, Graadt van Roggen JF, Cleton-Jansen AM, Baelde JJ, Hogendoorn PC: Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer 2001, 84:535-538
111. Gill S, McManus AP, Crew AJ, Benjamin H, Sheer D, Gusterson BA, Pinkerton CR, Patel K, Cooper CS, Shipley JM: Fusion of the EWS gene to a DNA segment from 9q22-31 in a human myxoid chondrosarcoma. Genes Chromosomes Cancer 1995, 12:307-310
112. Sjogren H, Wedell B, Meis-Kindblom JM, Kindblom LG, Stenman G, Kindblom JM: Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21). Cancer Res 2000, 60: 6832-6835
113. Attwooll C, Tariq M, Harris M, Coyne JD, Telford N, Varley JM: Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma. Oncogene 1999, 18:7599-7601
114. Naumann S, Krallman PA, Unni KK, Fidler ME, Neff JR, Bridge JA: Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma. Mod Pathol 2002, 15:572-576
115. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH: A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998, 18:184-187
116. Cools J, Wlodarska I, Somers R, Mentens N, Pedeutour F, Maes B, De Wolf-Peeters C, Pauwels P, Hagemeijer A, Marynen P: Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2002, 34:354-362
117. Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M: Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res 2001, 7:3977-3987
118. Nilsson M, Hoglund M, Panagopoulos I, Sciot R, Dal Cin P, Debiec-Rychter M, Mertens F, Mandahl N: Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors. Virchows Arch 2002, 441:475-480
119. Hibbard MK, Kozakewich HP, Dal Cin P, Sciot R, Tan X, Xiao S, Fletcher JA: PLAG1 fusion oncogenes in lipoblastoma. Cancer Res 2000, 60:4869-4872
120. Gisselsson D, Hibbard MK, Dal Cin P, Sciot R, Hsi BL, Kozakewich HP, Fletcher JA: PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms. Am J Pathol 2001, 159:955-962
121. Sozzi G, Minoletti F, Miozzo M, Sard L, Musso K, Azzarelli A, Pierotti MA, Pilotti S: Relevance of cytogenetic and fluorescent in situ hybridization analyses in the clinical assessment of soft tissue sarcoma. Hum Pathol 1997, 28:134-142
122. Pedeutour F, Simon MP, Minoletti F, Barcelo G, Terrier-Lacombe MJ, Combemale P, Sozzi G, Ayraud N, Turc-Carel C: Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. Cytogenet Cell Genet 1996, 72:171-174
123. O'Brien KP, Seroussi E, Dal Cin P, Sciot R, Mandahl N, Fletcher JA, Turc-Carel C, Dumanski JP: Various regions within the α-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer 1998, 23:187-193
124. Qi H, Dal Cin P, Hernandez JM, Garcia JL, Sciot R, Fletcher C, Van Eyken P, De Wever I, Van den Berghe H: Trisomies 8 and 20 in desmoid tumors. Cancer Genet Cytogenet 1996, 92:147-149
125. Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, Healey JH, Ueda T, Yoshikawa H, Meloni-Ehrig A, Sorensen PH, Mertens F, Mandahl N, van den Berghe H, Sciot R, Cin PD, Bridge J: The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001, 20:48-57
126. Maire G, Martin L, Michalak-Provost S, Gattas GJ, Turc-Carel C, Lorette G, Pedeutour F: Fusion of COL1A1 exon 29 with PDGFB exon 2 in a der(22)t(17;22) in a pediatric giant cell fibroblastoma with a pigmented Bednar tumor component: evidence for age-related chromosomal pattern in dermatofibrosarcoma protuberans and related tumors. Cancer Genet Cytogenet 2002, 134:156-161
127. Dehner LP: Some general considerations about the clinicopathologic aspects of soft tissue tumors. Pediatric Soft Tissue Tumors: A Clinical, Pathological, and Therapeutic Approach. Edited by Coffin MC, Dehner LP, O'Shea PA. Philadelphia, Williams & Wilkins, 1997, pp 1-14
128. Fletcher CDM UK, Mertens F (eds): World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon, IARC Press, 2002